Does Rallies show OM 10-K and 10-Q filings?

Rallies organizes OM SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is OM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.

OM (Outset Medical, Inc. Common Stock) Stock Analysis - SEC Filings

Outset Medical, Inc. Common Stock (OM) is a publicly traded Healthcare sector company. As of May 21, 2026, OM trades at $4.38 with a market cap of $68.96M and a P/E ratio of -1.04. OM moved +13.73% today. Year to date, OM is +15.26%; over the trailing twelve months it is -77.55%. Its 52-week range spans $3.00 to $25.35. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces OM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find OM SEC filings?

Rallies organizes OM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

OM Key Metrics

Key financial metrics for OM
Metric	Value
Price	$4.38
Market Cap	$68.96M
P/E Ratio	-1.04
EPS	$-4.07
Dividend Yield	0.00%
52-Week High	$25.35
52-Week Low	$3.00
Volume	0
Avg Volume	0
Revenue (TTM)	$117.59M
Net Income	$-74.85M
Gross Margin	40.64%

Latest OM News

Outset Medical Q1 Revenue Drops 6% to $27.9M, Gross Margin Rises to 43.4% — May 7, 2026
Analysts Project $28.9M Q1 Revenue for Outset Medical, Price Target of $9.00 — May 6, 2026
Outset Medical appoints Derick Elliott EVP to expand Tablo in nearly 1,000 facilities — Apr 6, 2026
Outset Medical Q4 Margins Jump 600bps, Price Targets Cut to $12 and $15 — Feb 20, 2026
Stifel Cuts Outset Medical Price Target to $8, Keeps Buy Rating — Feb 9, 2026

Recent OM Insider Trades

Trigg Leslie sold 3.44K (~$12.75K) on May 15, 2026.
Nash Marc sold 1.58K (~$5.85K) on May 15, 2026.
Brottem John L. sold 2.64K (~$9.76K) on May 15, 2026.

OM Analyst Consensus

4 analysts cover OM: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.50.

Common questions about OM

Where can I find OM SEC filings?: Rallies organizes OM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show OM 10-K and 10-Q filings?: Rallies organizes OM SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is OM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.